Alder Biopharmaceuticals Inc. Stock Price (ALDR)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

Is Principal’s BTEC the Healthcare ETF to Hold Come Election Day?Tue, 27 Oct 2020 10:25:08 UTC via ETF Trends
3M profit beats estimates on healthcare product boostTue, 27 Oct 2020 06:49:03 UTC via Yahoo Finance
5 Healthcare Stocks the Experts at Aquilo Capital Management Are Buying (1 Has Gained 88% This Month)Mon, 26 Oct 2020 23:54:35 UTC via Yahoo Finance
Medical Office Buildings, 5% Yield, 8% 2020 Growth: Healthcare Trust Of AmericaMon, 26 Oct 2020 09:15:00 UTC via Seeking Alpha
6%-7% Yields, 10%-16% Discounts: Tekla Healthcare Opportunities, Gabelli Healthcare & Wellness TrustFri, 23 Oct 2020 09:15:00 UTC via Seeking Alpha
The Principal Healthcare ETF Thriving under Vaccine ProgressThu, 22 Oct 2020 09:49:32 UTC via ETF Trends
Tenet Healthcare Corp's (THC) CEO Ron Rittenmeyer on Q3 2020 Results - Earnings Call TranscriptWed, 21 Oct 2020 17:46:03 UTC via Seeking Alpha
What Does Regis Healthcare Limited's (ASX:REG) Share Price Indicate?Wed, 21 Oct 2020 00:42:17 UTC via Yahoo Finance
Tenet Healthcare Corporation 2020 Q3 - Results - Earnings Call PresentationTue, 20 Oct 2020 16:34:37 UTC via Seeking Alpha
Allscripts Healthcare Solutions: Hidden ValueThu, 15 Oct 2020 06:35:20 UTC via Seeking Alpha

Alder Biopharmaceuticals Inc. Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:ALDR

You don't have any alerts set for IEX:ALDR.

About Alder Biopharmaceuticals Inc.

Alder BioPharmaceuticals Inc is a biotechnology company. It is engaged in the discovery, development, and commercialization of therapeutic antibodies addresses diseases with limited medical options. The company operates across the U.S and Australia.

CEORobert Azelby IndustryBiotechnology SectorHealthcare Websitehttp://www.alderbio.com Issue ExchangeNASDAQ Global Market Issue TypeUnknown

Real-time ALDR to USD Trade Analysis on IEX

Market Status Closed

Analysis is available when the exchange & market are open.